The Life and Accomplishments of Jorge Moll

Actions leading to the betterment of society are both commendable and recommendable. Jorge Moll strives to serve the community and embraces himself as among the noble individuals in the field of health through instituting developments to aid the less fortunate in the society. Jorge Moll is the president of the D’Or Institute for Research and Education Program, which put significant emphasis on neuroscience. He has pioneered the efforts to introduce neuroscience knowledge and its other facets to the world being among the first individuals to bring about a connection between volunteering and health matters.


As innovative as he is, Jorge Moll has a keen interest and active concern in the area of management in health. He boasts of a wide array of management and leadership skills, which has earned him both national and global recognition. As a man of the people, Moll conducts various public lectures to educate people of the dynamics emanating from health and innovation. He is an excellent advocate for the utilization of nouveau technology in hospitals to solve complex health issues. Notably, Jorge highlights the full range of national environments as well as their influence on the critical hospital management skill set.


In the Brazilian health industry, Jorge Moll is a big name, as he owns the largest group of hospitals, D’Or Sao Luiz. Under his management, the enterprise has grown to be among the most prominent groups of hospitals in the nation. Since 1997, as a small, single imaging laboratory, the group of hospitals has experienced remarkable success regarding additions to the services offered in their various branches throughout Brazil. As the chair of the group of hospitals, the firm has remarkably grown to own over 35 active branches with a capacity of more than 5000 beds in Brazil (Facebook).


Jorge Moll is an alumnus of the Federal University of Rio de Janeiro Medical School where he studied Neurology and graduated in 1997. After that, he proceeded to Faculty of Medicine of the University of Sao Paulo for his Ph.D. in Experimental Psychology ( With a tremendous entrepreneurial spirit, Jorge Moll achieved instant success through his idea of an imaging laboratory. From 2004 to 2007, Jorge Moll served at USA’s National Institute of Health based in Bethesda as a post-doctoral research fellow.


Mikhail Blagosklonny Is Inspiring A New Generation To Continue His Work For The Fight Against Cancer and Aging

There is a drug named Rapamycin that is also called Sirolimus, which is used for a spread of purposes including preventing organ transplant rejection, aiding coronary stents, treating unique lung disease, and for treating cancer. Dr. Mikhail Blagosklonny has heavily advocated the use of this drug to treat cancer and help people live a longer and happy life. Rapamycin has powerful immunosuppressant abilities, antifungal properties, and antiproliferative benefits and was found to not have the same bad side effects that other immunosuppresive drugs have. Specifically, it does not contain large amounts of toxins that effect the kidney like other drugs of its kind do.

Rapamycin has been used to treat cancer, and during the treatment of cancer patients it was discovered that it can increase the ability of the immune system to fight tumors and cause them to regress. This also means that the drug can help people who have had organ transplants to not get cancer. Along with this Rapamycin has the ability to suppress TSC in children, which is a disorder that encourages tumors to take hold in the kidneys, heart, and brain. Four out of five people that have TSC also end up with Facial angiofibromas, which is a rash of sorts that Rapamycin treates better than laser treatment does. Know more about Mikhail at

Dr. Mikhail Blagosklonny has been researching Rapamycin for many years, and he has found that it can help aging mice fight tuberculosis. He also believes that Rapamycin can increase the longevity of a person’s life and be a potential cure for Alzheimer’s disease. Other research has shown that Rapamycin might be effective in treating Muscular Dystrophy as well as Systemic Lupus Erythematosus. While research is still continuing, to this day, Dr. Blagosklonny has contributed a large part of what is currently known about Rapamycin. His determination and hard work has been the fuel that has inspired so many others to follow in his footsteps.

Mikhail Blagosklonny hopes to make the world a better place by working to bring affordable healthcare to all people. As a philanthropist, professor, and researcher, he knows his industry and has the passion to commit himself to the hours that it may take to make the changes he hopes to see. His specific interest is related to how aging and cancer are connected, and his contributions to the field of oncology have been extremely useful. Know more about Mikhail at Philly Purge.

Not only does Dr. Mikhail Blagosklonny look to treat cancer, but he is dedicating himself to find a way to treat it without the treatment being painful, tiring, and debilitating to the mind and body. Specifically, he has been working hard to find out how to destroy cancerous cells without effecting regular, healthy cells in the body. He has made a lot of headway, and many other people who work in the medical field have been inspired by his example. A lot of these individuals are hoping to take up the mantle and continue his work so future generations of cancer patients may benefit from the research of Dr. Blagosklonny.